South Dakota House Bill 1099: Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

South Dakota · 2026 Regular Session

What it does

Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

Latest action

Signed by the Governor on March 10, 2026 H.J. 547 (2026-03-10)

See how HB 1099 affects you on CapitolKey

Browse more bills · CapitolKey home